Clinical Trial

vEAET-H for Chronic Pain Patients Using Medical Cannabis in Israel - A Feasibility Study

Study acronym: vEAET-H
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to evaluate whether a culturally adapted, virtual, group-based emotional therapy called Emotional Awareness and Expression Therapy is feasible and whether it can help reduce chronic pain and improve emotional well-being among Israeli adults who suffer from chronic musculoskeletal pain and are treated with medical cannabis. Participants will attend a weekly 1.5-hour virtual group therapy session for 8 weeks, except for the first session, which will be held in-person at the hospital's clinic. The participants will take part in group discussions and emotional processing exercises, complete questionnaires about pain levels, mood, sleep, and quality of life, and continue their usual medical treatment as prescribed by their doctors.
Trial Details
NCT Number NCT07732062
Lead Sponsor Reuth Rehabilitation Hospital
Conditions Chronic Musculoskeletal Pain, Cannabis Use
Enrollment 42 participants
Start Date 2026-10-01
Primary Completion 2027-10-01 (estimated)
Study Completion 2027-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-28